Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2175 of 2529 entries
View as:

Real-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP)

Phase: N/A Priority: Normal
NCT ID: NCT06211153 Org: User:
Start: 12/31/21 End: 12/15/22 Due: 12/15/23

Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT04645589 Org: User:
Start: 03/16/21 End: 07/31/25 Due: 07/31/26

Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy

Phase: N/A Priority: Normal
NCT ID: NCT05376579 Org: User:
Start: 06/17/22 End: 06/30/26 Due: 06/30/27

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

Phase: N/A Priority: Normal
NCT ID: NCT05976230 Org: User:
Start: 09/04/23 End: 09/30/25 Due: 09/30/26

Kesimpta (Ofatumumab) Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT05634967 Org: User:
Start: 01/05/23 End: 02/28/33 Due: 02/28/34

Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.

Phase: N/A Priority: Normal
NCT ID: NCT00170794 Org: User:
Start: 09/30/04 End: - Due: -

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT00809159 Org: User:
Start: 03/31/09 End: 05/31/11 Due: 05/31/12

Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea

Phase: N/A Priority: Normal
NCT ID: NCT01019473 Org: User:
Start: 11/30/09 End: - Due: -

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study

Phase: N/A Priority: Normal
NCT ID: NCT01326845 Org: User:
Start: 12/31/11 End: 09/30/12 Due: 09/30/13

QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00581997 Org: User:
Start: 12/31/07 End: - Due: -

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT00887588 Org: User:
Start: 11/30/09 End: 12/31/11 Due: 12/31/12

Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care

Phase: N/A Priority: Normal
NCT ID: NCT06004453 Org: User:
Start: 04/04/23 End: 01/17/25 Due: 01/17/26

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06947993 Org: User:
Start: 05/16/25 End: 11/27/28 Due: 11/27/29

Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study

Phase: N/A Priority: Normal
NCT ID: NCT06851845 Org: User:
Start: 02/01/26 End: 02/01/28 Due: 02/01/29

A Study of WVT078 in Patients With Multiple Myeloma (MM)

Phase: N/A Priority: Normal
NCT ID: NCT04123418 Org: User:
Start: 12/05/19 End: 12/02/24 Due: 12/02/25

A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00758524 Org: User:
Start: 09/11/08 End: 07/02/09 Due: 07/02/10

Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients

Phase: N/A Priority: Normal
NCT ID: NCT02002221 Org: User:
Start: 12/31/13 End: 02/28/15 Due: 02/28/16

Safety, Tolerability, and Pharmacokinetics of XXB750 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06558097 Org: User:
Start: 07/29/20 End: 03/31/23 Due: 03/31/24

A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05447663 Org: User:
Start: 02/23/23 End: 10/26/23 Due: 10/26/24

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01922271 Org: User:
Start: 08/31/13 End: 01/31/14 Due: 01/31/15

Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Phase: N/A Priority: Normal
NCT ID: NCT02534909 Org: User:
Start: 09/09/15 End: 05/24/22 Due: 05/24/23

Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT05232864 Org: User:
Start: 08/22/22 End: 08/23/23 Due: 08/23/24

Non-small Cell Lung Cancer Registry

Phase: N/A Priority: Normal
NCT ID: NCT00099541 Org: User:
Start: 11/30/04 End: 11/30/07 Due: 11/30/08

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

Phase: N/A Priority: Normal
NCT ID: NCT01555138 Org: User:
Start: 02/29/12 End: 02/28/14 Due: 02/28/15

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

Phase: N/A Priority: Normal
NCT ID: NCT01362608 Org: User:
Start: 06/20/11 End: 05/19/15 Due: 05/19/16